|
US4120960A
(en)
*
|
1973-10-31 |
1978-10-17 |
The Boots Company Limited |
Therapeutic agents
|
|
NL7702763A
(nl)
*
|
1976-03-18 |
1977-09-20 |
Takio Shimamoto En Masayuki Is |
Werkwijze voor de bereiding van thromboxaan- -antagonisten en van preparaten die deze stof- fen bevatten.
|
|
IE47592B1
(en)
*
|
1977-12-29 |
1984-05-02 |
Ici Ltd |
Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
|
|
US4293553A
(en)
*
|
1978-08-11 |
1981-10-06 |
Masayuki Ishikawa |
1-Phthalazone derivatives, and use thereof
|
|
US4464532A
(en)
*
|
1979-07-31 |
1984-08-07 |
Nippon Kayaku Kabushiki Kaisha |
Intermediates of 7-alkoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1-phthalazone
|
|
JPS5668609A
(en)
*
|
1979-11-07 |
1981-06-09 |
Nippon Kayaku Co Ltd |
Phthalazinol preparation
|
|
JPS58116471A
(ja)
*
|
1981-12-29 |
1983-07-11 |
Nippon Kayaku Co Ltd |
４−ヒドロキシメチル−１−フタラゾンエステル誘導体およびその塩
|
|
GB2127805A
(en)
*
|
1982-09-13 |
1984-04-18 |
Showa Denko Kk |
Phthalazones
|
|
US4861778A
(en)
*
|
1986-06-16 |
1989-08-29 |
Research Corporation |
2,3-dihydrophthalazine-1,4-diones
|
|
US5177075A
(en)
*
|
1988-08-19 |
1993-01-05 |
Warner-Lambert Company |
Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process
|
|
ATE117553T1
(de)
*
|
1988-08-19 |
1995-02-15 |
Warner Lambert Co |
Substituierte dihydroisochinolinone und verwandte verbindungen als verstärker der letalen effekte von bestrahlung und bestimmten chemotherapeutika; ausgewählte verbindungen, analoga und verfahren.
|
|
DE4333761A1
(de)
*
|
1993-10-04 |
1995-04-06 |
Luitpold Pharma Gmbh |
Heterocyclische Carbamate, Verfahren zu ihrer Herstellung und Arzneimittel
|
|
RU2169139C1
(ru)
*
|
2000-08-02 |
2001-06-20 |
Закрытое акционерное общество "Центр современной медицины "Медикор" |
Способ получения щелочных и щелочноземельных солей 5-амино-2,3-дигидро-1,4-фталазиндиона
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
CA2688161C
(en)
|
2007-06-04 |
2020-10-20 |
Kunwar Shailubhai |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
EP2810951B1
(en)
|
2008-06-04 |
2017-03-15 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
ES2624828T3
(es)
|
2008-07-16 |
2017-07-17 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
|
|
ES2525748T3
(es)
|
2009-11-13 |
2014-12-29 |
Toray Industries, Inc. |
Agente terapéutico o profiláctico para la diabetes
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
EP3366698A1
(en)
|
2011-03-01 |
2018-08-29 |
Synergy Pharmaceuticals Inc. |
Guanylate cyclase c agonists
|
|
CA2902348C
(en)
|
2013-02-25 |
2021-11-30 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
|
US9708367B2
(en)
|
2013-03-15 |
2017-07-18 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase and their uses
|
|
JP2016514670A
(ja)
|
2013-03-15 |
2016-05-23 |
シナジー ファーマシューティカルズ インコーポレイテッド |
他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
|
|
SI3004138T1
(sl)
|
2013-06-05 |
2024-07-31 |
Bausch Health Ireland Limited |
Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
|
|
IL280864B2
(en)
|
2013-08-09 |
2024-03-01 |
Ardelyx Inc |
Compounds and methods for inhibiting phosphate transport
|
|
EP3972599A1
(en)
|
2019-05-21 |
2022-03-30 |
Ardelyx, Inc. |
Combination for lowering serum phosphate in a patient
|